RD
About
Dana's experience includes over 20 years of senior management in public and private biotech companies. Most recently, he was a co-founder, President and CEO of IntraImmune Therapies, Inc., a biotechnology company which he sold to Abgenix, Inc. (Nasdaq:ABGX) in 2000. Prior to heading IntraImmune, he was founder and principal manager of several successful early stage biotech companies in the Boston area.
Position in the VCSift Database
- • 7 investors at Vimac Ventures are tracked.
- • 1,801 investors hold the Managing Director role in VCSift. R. Dana Ono, PhD is one of them.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
Contact Information
linkedin.com/in/••••••••
Find more investors like R.
Search Investors